Document Detail

Thyroid cancer development and progression: emerging role of cancer stem cells.
MedLine Citation:
PMID:  22691885     Owner:  NLM     Status:  In-Data-Review    
Thyroid cancer is the most common endocrine malignancy. Although the majority of thyroid cancers are well differentiated and have a favorable prognosis, a minor proportion are poorly differentiated malignancies, which show an aggressive behavior and are refractory to conventional cancer treatments. The molecular mechanisms underlying thyroid development and progression are incompletely understood. Most of thyroid tumorigenesis models propose that thyroid cancer originates from the normal thyrocytes that, via the accumulation of genetic alterations, acquire a malignant phenotype and the ability to metastatize. However, recent progress in clarifying the molecular mechanisms of thyroid embryogenesis/development and the discovery of fetal/stem-like cells within the thyroid gland, have raised the possibility that thyroid cancer originates from progenitor/stem cells. These cells have the ability to self-renew and to undergo multilineage differentiation, and are resistant to common anticancer treatments. Thyroid progenitor/stem cells have been isolated from thyroid cancer and the normal counterpart. Further insights in the biology of these cells will open new perspectives in terms of prevention, diagnosis and therapy of thyroid cancers, especially those with an aggressive behaviour. More effective protocols for the identification and isolation of thyroid cancer stem cells will allow us to specifically and safely target these cells with the aim to definitely eradicate aggressive thyroid cancers.
R Malaguarnera; A Morcavallo; S Giuliano; A Belfiore
Related Documents :
12767595 - The association of vitamins c and k3 kills cancer cells mainly by autoschizis, a novel ...
11562285 - Vitamin d analogs: mechanism of action and therapeutic applications.
6299545 - Fiber, steroids, and cancer.
1917235 - Diet and cancer of the colon and rectum: a case-control study in china.
23773345 - Manganese superoxide dismutase ile58thr, catalase c-262t and myeloperoxidase g-463a gen...
25003655 - Outcomes of patients with low-risk endometrial cancer surgically staged without lymphad...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Minerva endocrinologica     Volume:  37     ISSN:  0391-1977     ISO Abbreviation:  Minerva Endocrinol.     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-06-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8406505     Medline TA:  Minerva Endocrinol     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  103-15     Citation Subset:  IM    
Endocrinology Unit, Department of Health, University Magna Graecia of Catanzaro, Catanzaro, Italy -
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Combination of Hypoxic Preconditioning and Postconditioning Does Not Induce Additive Protection of E...
Next Document:  Endometrial carcinoma tumorigenesis and pharmacotherapy research.